Clinical Trial Update: Targeted Potassium Levels for Prevention of ICD Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining targeted potassium levels to prevent ICD therapies in patients with ventricular arrhythmias, cardiac arrest, and atrial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Cardiac Arrest
• Ventricular Arrhythmias

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Ventricular Arrhythmias and Cardiac Arrest, Implantable Defibrillator User | Phase 4 | Status: ACTIVE_NOT_RECRUITING